FILING ANALYSIS · WEDNESDAY, OCTOBER 28
BOSTON SCIENTIFIC CORP BSX — 8-K: Results of Operations and Financial Condition
neutral
Boston Scientific reported 1.5% net sales growth and adjusted EPS of $0.73, slightly below last year's $0.75, with mixed segment and regional performances, and announced several new product clearances and collaborations, but no major quantified surprises to drive significant stock movement
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →